The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma
- 30 August 2019
- journal article
- review article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (1) , 35-42
Abstract
In-transit melanoma represents a distinct disease pattern in which melanoma recurs as dermal or subcutaneous nodules between the primary melanoma site and the draining regional lymph node basin. The...Keywords
This publication has 65 references indexed in Scilit:
- Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanomaInternational Journal of Hyperthermia, 2013
- Current Trends in Regional Therapy for Melanoma: Lessons Learned from 225 Regional Chemotherapy Treatments between 1995 and 2010 at a Single InstitutionJournal of the American College of Surgeons, 2011
- Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and SafetyThe Oncologist, 2010
- Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment ParametersJournal of Clinical Oncology, 2010
- Isolated Limb Infusion for Malignant Melanoma: Predictors of Response and OutcomeAnnals of Surgical Oncology, 2009
- Isolated Limb Infusion for In-Transit Malignant Melanoma of the Extremity: A Well-Tolerated but Less Effective Alternative to Hyperthermic Isolated Limb PerfusionAnnals of Surgical Oncology, 2008
- The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph NodesJournal of Clinical Oncology, 2005
- Protection against melanoma by vaccination with Bacille Calmette-Guérin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological controlEuropean Journal of Cancer, 2005
- Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patientsEuropean Journal of Cancer, 2005
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology, 2000